share_log

Maxim Group Initiates Coverage On Helius Medical Tech With Buy Rating, Announces Price Target of $1

Maxim Group Initiates Coverage On Helius Medical Tech With Buy Rating, Announces Price Target of $1

Maxim集团以买入评级开始对Helius Medical Tech进行报道,宣布目标价为1美元
Benzinga Real-time News ·  2022/12/20 08:48

Maxim Group analyst Anthony Vendetti initiates coverage on Helius Medical Tech (NASDAQ:HSDT) with a Buy rating and announces Price Target of $1.

Maxim Group分析师Anthony Vendetti对Helius Medical Tech(纳斯达克:HSDT)发起买入评级,并宣布目标价为1美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发